Tobi Berchen, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 4638 Genesee St, Geneseo, NY 14454 Phone: 585-243-4041 Fax: 585-243-5415 |
Jordanne Donielle Swanson, NP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 50 E South St, Geneseo, NY 14454 Phone: 585-243-9340 |
Mrs. Judith Clair Moore, CPNP Pediatrics Medicare: Medicare Enrolled Practice Location: 3889 North Rd, Geneseo, NY 14454 Phone: 585-243-4000 Fax: 585-243-4002 |
Jean Barnett Mooney, PED NURSE PRACTITION Pediatrics Medicare: Medicare Enrolled Practice Location: 3889 North Road, Geneseo, NY 14454 Phone: 585-243-4000 Fax: 585-243-4002 |
News Archive
Cutting-edge technology company Quantum International Corp. announced today that it has begun development on an innovative new accessory for the Apple iPad that could potentially revolutionize mobile medical testing.
Gene expression in breast cancer provides valuable biological information for better determining the diagnosis, treatment, risk of relapse and survival rate. However, the most common form of characterizing breast cancer is by histopathological techniques. This study, headed by Dr Aleix Prat, Head of the Translational Genomics Group at the Vall d'Hebron Institute of Oncology (VHIO) and an oncologist at the Breast Cancer Unit of the Vall dĀ“Hebron University Hospital, focused on hormone-sensitive breast tumours known as luminals.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on September 11th, 2009, on the eighth anniversary of the World Trade Center attacks, the company won a competitive bid from the Centers for Disease Control in Atlanta, Georgia to manufacture devices designed to combat global bioterrorism.
While cigarette smoking has long been on the decline, marijuana use is on the rise and, disproportionately, marijuana users also smoke cigarettes. A new study by researchers at Columbia University's Mailman School of Public Health and the City University of New York reports that cannabis use was associated with an increased initiation of cigarette smoking among non-cigarette smokers.
Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC).
› Verified 8 days ago